SODIUM BICARBONATE INJECTION, USP
FRESENIUS KABI CANADA LTD
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is SODIUM BICARBONATE INJECTION, USP discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that SODIUM BICARBONATE INJECTION, USP 42MG has been permanently discontinued (last updated October 3, 2024). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is SODIUM BICARBONATE INJECTION, USP not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
SODIUM BICARBONATE INJ 4.2%
INTERNATIONAL MEDICATION SYSTEMS LTD.
SODIUM BICARBONATE INJ 7.5%
INTERNATIONAL MEDICATION SYSTEMS LTD.
SODIUM BICARBONATE INJECTION 84MG/ML
ASTRAZENECA CANADA INC
SODIUM BICARBONATE TAB 600MG
D.C. LABS LIMITED
800 SODIUM BICARBONATE POWDER
BAXTER CORPORATION
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
EPINEPHRINE INJECTION USP, SODIUM BICARBONATE INJECTION USP & DEXTROSE INJECTION USP
EPINEPHRINE, SODIUM BICARBONATE & DEXTROSE USP INJECTIONS : Possible microbiological contamination.
Highest health risk
Possible match — not confirmed
Sodium Acetate Injection USP
Sodium Acetate Injection USP; Incorrect GTIN
Moderate health risk
Possible match — not confirmed
Sodium Acetate Injection, USP
Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter
Possible match — not confirmed
Sodium Acetate Injection, USP
Sodium Acetate Injection, USP: Particulate matter
Highest health risk
Possible match — not confirmed
DIN
02486628
Strength
42MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Compare with another product →
Shortage History
Other Products from FRESENIUS KABI CANADA LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
900MG · DIN 02395150
20MG · DIN 02538644
50MG · DIN 02403536
50MG · DIN 02236926
DIN 02497697
3MG · DIN 02457482
3MG · DIN 02267659
3MG · DIN 02457474
50MG · DIN 02245248
250MG · DIN 02227029
2G · DIN 02226995
1G · DIN 02227002